Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations

BRCA1andBRCA2mutations in ovarian cancer patients from China: ethnic-related mutations inBRCA1associated with an increased risk of ovarian cancer

(2017) Tingyan Shi et al.   INTERNATIONAL JOURNAL OF CANCER

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer

(2017) Fergus J. Couch et al.   JAMA Oncology

Improving performance of multigene panels for genomic analysis of cancer predisposition

(2016) Brian H. Shirts et al.   GENETICS IN MEDICINE

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer

(2016) Nadine Tung et al.   JOURNAL OF CLINICAL ONCOLOGY

Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India

(2016) Ashraf U Mannan et al.   JOURNAL OF HUMAN GENETICS

Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing

(2016) Wenbo Mu et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Genetic differentiation and population structure of five ethnic groups of Punjab (North-West India)

(2016) Gagandeep Singh et al.   MOLECULAR GENETICS AND GENOMICS

The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?

(2016) Marie Eliade et al.   Oncotarget

Targeted Resequencing of 30 Genes Improves the Detection of Deleterious Mutations in South Indian Women with Breast and/or Ovarian Cancers

(2015) Thangarajan Rajkumar et al.   Asian Pacific Journal of Cancer Prevention

PARP inhibitors in the management of breast cancer: current data and future prospects

(2015) Luca Livraghi et al.   BMC Medicine

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing

(2015) Lisa R. Susswein et al.   GENETICS IN MEDICINE

Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger Sequencing

(2015) Linnea M. Baudhuin et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients

(2015) Stephen E. Lincoln et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

(2015) Douglas F. Easton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment

(2015) Andrea Desmond et al.   JAMA Oncology

Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes

(2014) Laurent Castéra et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

A Comprehensive Focus on Global Spectrum ofBRCA1andBRCA2Mutations in Breast Cancer

(2013) Fatemeh Karami et al.   Biomed Research International

Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations

(2012) Yael Laitman et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Breast Cancer Care in India: The Current Scenario and the Challenges for the Future

(2008) Gaurav Agarwal et al.   Breast Care

Hereditary breast cancer: new genetic developments, new therapeutic avenues

(2008) Philippe M. Campeau et al.   HUMAN GENETICS